The
Competition and Markets Authority (CMA) has published its provisional report on
its market study into infant formula and follow-on formula in the UK. The CMA invites comments on its
interim report by 29 November 2024.
The study
concerns infant and follow-on formula as defined by European Commission
Regulation 2016/127, and formulas labelled as foods for special medical
purposes that can be sold without prescription under Regulation 2016/128.
The CMA
found that the market has a highly concentrated structure. It identified concerns relating to the unintended
consequences of regulations designed to support public health goals, a lack of
timely, clear and impartial information for parents about formula, and companies'
responses to regulations around marketing.
The CMA
raised concerns about how this impacts pricing, and limited competition on
formula prices at the retail level.
The CMA has
explored potential solutions. Recommendations cover the provision of clear,
accurate and impartial information, including on the nutritional sufficiency of
infant formula products, in both healthcare and retail contexts.
The CMA
recommends strengthening labelling and advertising rules to moderate the role
of brand awareness in decision-making in the market.
The CMA’s provisional
findings echo concerns raised by customers.
The provisional findings bring together multiple tools from competition
law oriented remedies to consumer protection measures around promotions at the
retail level.
The deadline
for the CMA to publish its final report is 19 February 2025.
https://www.gov.uk/government/news/infant-formula-cma-sets-out-concerns-and-potential-solutions